Oric Pharmaceuticals, Inc.·4

Jun 15, 4:58 PM ET

You Angie 4

4 · Oric Pharmaceuticals, Inc. · Filed Jun 15, 2023

Insider Transaction Report

Form 4
Period: 2023-06-14
You Angie
Director
Transactions
  • Award

    Stock Option (right to buy)

    2023-06-14+20,50020,500 total
    Exercise: $6.33Exp: 2033-06-13Common Stock (20,500 underlying)
Footnotes (1)
  • [F1]One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) June 14, 2024 or (ii) the business day prior to the next annual meeting of the Issuer's stockholders that occurs following the date of grant.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION